Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05738213 · ClinicalTrials.gov registry record · NA
Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine
A NA study of Migraine, sponsored by Washington University School of Medicine.
- Active
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT05738213: Active NA study of Migraine, sponsored by Washington University School of Medicine.
NCT05738213 is a NA study of Migraine that is active but no longer recruiting, run by Washington University School of Medicine. The registered enrollment target is 100 participants, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05738213, a NA study of Migraine, is active but no longer recruiting, sponsored by Washington University School of Medicine.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to investigate the relationships between sex hormone levels and experimental pain sensitivity and migraine severity will be examined.
Primary Outcome
This psychophysical test examine the inhibitory pain modulation efficiency. In this test, pressure pain thresholds (measures by kilopascal) are assessed before and during immersion of the foot in cold water.
Conditions Studied
Interventions
- DEVICE Pressure stimuli
- BEHAVIORAL Pain ratings
- BEHAVIORAL Pressure pain thresholds (PPT)
- DEVICE Thermal stimuli
- BEHAVIORAL Conditioned pain modulation (CPM) response
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2023-01-10 |
| Est. Completion | 2028-01-01 |
| Phase | NA |
What the registry record for NCT05738213 still lists
NCT05738213 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 357-participant average among 102 other Migraine trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Migraine appearing as the primary indexed condition, and to 5 interventions - of which Pressure stimuli is the first listed.
NCT05738213 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT05738213 about?
NCT05738213 is a clinical study titled "Puberty, Sex Hormones and Pain Sensitivity in Adolescents With Migraine". The purpose of this research study is to investigate the relationships between sex hormone levels and experimental pain sensitivity and migraine severity will be examined.
What is the current status of trial NCT05738213?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2023-01-10. Estimated completion is 2028-01-01.
What conditions does trial NCT05738213 study?
This clinical trial studies the following conditions: Migraine.
What interventions are being tested in trial NCT05738213?
The interventions under investigation include: Pressure stimuli (DEVICE), Pain ratings (BEHAVIORAL), Pressure pain thresholds (PPT) (BEHAVIORAL), Thermal stimuli (DEVICE), Conditioned pain modulation (CPM) response (BEHAVIORAL).
Who is sponsoring clinical trial NCT05738213?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05738213 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Migraine
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05738213's enrollment target sits among peer trials
100 58th of 102 higher than 42 of 102 other Migraine trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Migraine trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
MMA Embolization for Refractory Chronic Migraine
RECRUITING · NA
-
Stimulation of External Carotid Artery Circulation
RECRUITING · NA
-
Responding With Evidence and Access for Childhood Headaches
RECRUITING · NA
-
Determining the Utility of a Behavioral Intervention in Chronic Migraine
RECRUITING · NA
-
Cocoa Extract for Migraine Trial
RECRUITING · NA
-
Migraine in Adolescents
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI